Chargement en cours...
Breast cancer therapy for BRCA1 carriers: moving towards platinum standard?
<p>Abstract</p> <p>Recently Byrski et al. reported the first-ever breast cancer (BC) study, which specifically selected BRCA1-carriers for the neoadjuvant treatment and used monotherapy by cisplatin instead of conventional schemes. Although the TNM staging of the recruited patients...
Enregistré dans:
Auteur principal: | |
---|---|
Format: | Artigo |
Langue: | Inglês |
Publié: |
BMC
2009-04-01
|
Collection: | Hereditary Cancer in Clinical Practice |
Accès en ligne: | http://www.hccpjournal.com/content/7/1/8 |
Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|